A systematic review of prognostic factors at the end of life for people with a hematological malignancy.

BMC Cancer 2017 03 23;17(1):213. Epub 2017 Mar 23.

Queensland University of Technology, Victoria Park Road, N Block, Brisbane, QLD, 4059, Australia.

Background: Accurate prognosticating is needed when patients are nearing the end of life to ensure appropriate treatment decisions, and facilitate palliative care provision and transitioning to terminal care. People with a hematological malignancy characteristically experience a fluctuating illness trajectory leading to difficulties with prognosticating. The aim of this review was to identify current knowledge regarding 'bedside' prognostic factors in the final 3 months of life for people with a hematological malignancy associated with increased risk of mortality.

Methods: A systematic review of the literature was performed across: PubMed; CINAHL; PsycINFO; and Cochrane with set inclusion criteria: 1) prognostic cohort studies; 2) published 2004-2014; 3) sample ≥ 18 years; 4) >50% sample had a hematological malignancy; 5) reported 'bedside' prognostic factors; 6) median survival of <3 months; and 7) English language. Quality appraisal was performed using the Quality In Prognostic Studies (QUIPS) tool. Results are reported in line with PRISMA guidelines.

Results: The search returned 4860 studies of which 28 met inclusion criteria. Twenty-four studies were rated moderate quality, three were high quality and one study was deemed to be of low quality. Most studies were set in the ICU (n = 24/28) and were retrospective (n = 25/28). Forty 'bedside' prognostic factors were identified as associated with increased risk of mortality encompassing the following broad categories: 1) demographics; 2) physiological complications or conditions; 3) disease characteristics; 4) laboratory blood values; and 5) interventions.

Conclusions: The literature on prognosticating in the final months of life was predominantly focused on people who had experienced acute physiological deterioration and were being treated aggressively in the in-patient setting. A significant gap in the literature exists for people who are treated less aggressively or are on a palliative trajectory. Findings did not report on, or confirm the significance of, many of the key prognostic factors associated with increased risk of mortality at the end of life in the solid tumour population, demonstrating key differences in the two populations.

Trial Registration: This systematic review was not registered.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3207-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364562PMC
March 2017
27 Reads

Publication Analysis

Top Keywords

hematological malignancy
16
prognostic factors
12
people hematological
12
life people
8
systematic review
8
'bedside' prognostic
8
final 3 months
4
factors final
4
knowledge 'bedside'
4
3 months life
4
risk mortalitymethods
4
mortalitymethods systematic
4
increased risk
4
associated increased
4
malignancy associated
4
current knowledge
4
review literature
4
illness trajectory
4
fluctuating illness
4
experience fluctuating
4

References

(Supplied by CrossRef)

D Rodriguez-Abreu et al.
Ann Oncol 2007

C Pallister et al.
2011

A Gordon et al.
Anaesthesia 2005

Y-S Hung et al.
Am J Hosp Palliat Med 2013

V Manitta et al.
J Palliat Med 2010

K Auret et al.
Intern Med J 2003

P McGrath et al.
J Palliat Care 1999

P McGrath et al.
European Journal of Cancer Care 2007

WHO et al.
2012

NICE et al.
2003

A Viganò et al.
Palliat Med 2000

Similar Publications